31
Participants
Start Date
September 30, 2003
Primary Completion Date
January 31, 2009
Study Completion Date
August 31, 2013
epoetin alfa
Epoetin alfa will be administered 80,000 u sc every week commencing on study day 1.
Case Comprehensive Cancer Center, Cleveland
National Cancer Institute (NCI)
NIH
The Cleveland Clinic
OTHER